Tracking the behavioural and social drivers of adult influenza vaccination: insights from Australia's first serial survey Read more about Tracking the behavioural and social drivers of adult influenza vaccination: insights from Australia's first serial survey3 views
The live attenuated influenza vaccine in Australia: an additional tool for influenza prevention Read more about The live attenuated influenza vaccine in Australia: an additional tool for influenza prevention5 views
Coadministered influenza and pertussis containing vaccines in pregnant women Read more about Coadministered influenza and pertussis containing vaccines in pregnant women7 views
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia Read more about Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia3 views
Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapies Read more about Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapies4 views
Improving school vaccinations for adolescents with intellectual and developmental disabilities: a person-centred approach Read more about Improving school vaccinations for adolescents with intellectual and developmental disabilities: a person-centred approach3 views
Electronic, self-reported active vaccine safety surveillance: a three-country comparison of AusVaxSafety (Australia), CANVAS (Canada) and V-safe (United States) Read more about Electronic, self-reported active vaccine safety surveillance: a three-country comparison of AusVaxSafety (Australia), CANVAS (Canada) and V-safe (United States)5 views
Immunogenicity and safety of a 2 + 1 DTPa priming schedule in Australian infants and the impact of maternally derived antibodies on pertussis antibody responses up to 4 years of age Read more about Immunogenicity and safety of a 2 + 1 DTPa priming schedule in Australian infants and the impact of maternally derived antibodies on pertussis antibody responses up to 4 years of age10 views
The role of serological testing for vaccination with a focus on immunocompromised patients: a synthesis of current evidence Read more about The role of serological testing for vaccination with a focus on immunocompromised patients: a synthesis of current evidence12 views
Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022 Submitted by Jackson.young on Fri, 19/09/2025 The Therapeutic Goods Administration monitors the safety of vaccines in Australia by collecting and reviewing spontaneous reports of adverse events following immunisation. This report describes the data collected through this spontaneous surveillance system in 2022 for all vaccines other than COVID-19 vaccines. Read more about Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2022150 views
